Rice Hall James & Associates, LLC Axogen, Inc. Transaction History
Rice Hall James & Associates, LLC
- $1.53 Billion
- Q1 2025
A detailed history of Rice Hall James & Associates, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 189,113 shares of AXGN stock, worth $3.1 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
189,113
Previous 190,968
0.97%
Holding current value
$3.1 Million
Previous $3.15 Million
11.15%
% of portfolio
0.23%
Previous 0.19%
Shares
9 transactions
Others Institutions Holding AXGN
# of Institutions
181Shares Held
36.6MCall Options Held
82.6KPut Options Held
1.1K-
First Light Asset Management, LLC Edina, MN4.51MShares$74 Million7.26% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$53.3 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.96MShares$48.5 Million3.39% of portfolio
-
Morgan Stanley New York, NY2.43MShares$39.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$39.8 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $694M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...